(Natural News) Drug factories are potentially the next “collateral damage” of the COVID-19 outbreak. This is after the U.S. Food and Drug Administration (FDA) announced on Thursday that a manufacturer alerted the agency about a disruption in its supply of a certain human drug. FDA commissioner Stephen Hahn said the shortage is due to an… |